Amanta healthcare limited IPO Overview
Amanta healthcare limited IPO is a Mainboard public issue offered through a Book Building issue with a total issue size of ₹— crores. The IPO price band is set at ₹120 to ₹126 per share, and retail investors can apply with a minimum investment of ₹14,994 as per IPO guidelines.
The Amanta healthcare limited IPO opens on 1 Sept 2025 and closes on 3 Sept 2025. The IPO allotment is expected to be finalized on 4 Sept 2025, and the equity shares are proposed to be listed on BSE, NSE on 9 Sept 2025.
Investors can refer to the Amanta healthcare limited IPO RHP-DRHP for detailed information. The issue is managed by Beeline Capital Advisors Pvt.Ltd. as the book running lead manager, while MUFG Intime India Private Limited (Link Intime) is the registrar to the IPO. Before investing, market participants often review IPO details, valuation, PE ratio, financials, and risk factors.
About amanta healthcare limited
The company manufactures fluid therapy formulations, including IV fluids, diluents, ophthalmic solutions, and respiratory care products. It also offers irrigation solutions, first-aid products, and eye lubricants in the medical device segment.
The company markets products through three business units:
National sales,
International sales and
Product partnering with various foreign and Indian pharmaceutical companies.
The company manufactures over 45 generic products, marketing them under their brands in India through 320 distributors and stockists.
The company sells products in Africa, Latin America, the UK, and beyond. Its products are registered in 19 countries and comply with various regulations. In Fiscal 2025, the company exported branded products to 21 countries.
As of March 31, 2025, the company has a team of 1,718 employees at its formulation and development and quality laboratory.
Competitive Strengths
Well-established manufacturer of pharmaceutical formulations with a diverse product portfolio and diverse market.
Large manufacturing capabilities
Wide Domestic and International Marketing Network.
Experienced management team supported by a large, diverse and skilled workforce.
Investment Objective
Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat
General corporate purposes